BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28300591)

  • 1. miR-455 inhibits breast cancer cell proliferation through targeting CDK14.
    Wang B; Zou A; Ma L; Chen X; Wang L; Zeng X; Tan T
    Eur J Pharmacol; 2017 Jul; 807():138-143. PubMed ID: 28300591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
    Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y
    Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14.
    Li Q; Zhou L; Wang M; Wang N; Li C; Wang J; Qi L
    Biomed Pharmacother; 2018 Feb; 98():636-642. PubMed ID: 29289838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-431 inhibits cell proliferation and induces cell apoptosis by targeting CDK14 in pancreatic cancer.
    Yang J; Zhu H; Jin Y; Song Y
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4493-4499. PubMed ID: 30058687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK14/β-catenin/TCF4/miR-26b positive feedback regulation modulating pancreatic cancer cell phenotypes in vitro and tumor growth in mice model in vivo.
    Sun Y; Wang P; Zhang Q; Wu H
    J Gene Med; 2022 Feb; 24(2):e3343. PubMed ID: 33871149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of cyclin-dependent kinases in miR-193a5p regulating ovarian cancer cell proliferation and epithelial mesenchymal transformation].
    Yang ZJ; DU XL
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Mar; 36(2):176-179. PubMed ID: 32744015
    [No Abstract]   [Full Text] [Related]  

  • 9. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression.
    Xia H; Long J; Zhang R; Yang X; Ma Z
    Biomed Pharmacother; 2015 Oct; 75():105-10. PubMed ID: 26276160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer.
    Li J; Shao W; Feng H
    Biomed Pharmacother; 2019 Feb; 110():850-856. PubMed ID: 30557834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-205 Inhibits Sporadic Vestibular Schwannoma Cell Proliferation by Targeting Cyclin-Dependent Kinase 14.
    Yin X; Huo Z; Yan S; Wang Z; Yang T; Wu H; Zhang Z
    World Neurosurg; 2021 Mar; 147():e25-e31. PubMed ID: 33217595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
    Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
    Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.
    Feng T; Xu D; Tu C; Li W; Ning Y; Ding J; Wang S; Yuan L; Xu N; Qian K; Wang Y; Qi C
    Tumour Biol; 2015 Aug; 36(8):5987-97. PubMed ID: 25731732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
    Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H
    Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
    Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
    Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1.
    Wang D; Ren J; Ren H; Fu JL; Yu D
    Acta Pharmacol Sin; 2018 Jan; 39(1):124-131. PubMed ID: 28816236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.